| Product Information |
|
| Registration Number |
BR-508
|
| Generic Name |
Diphtheria, Tetanus and Pertussis (acellular
component), Hepatitis B (rDNA), Poliomyelitis (inactivated) and Haemophilus influenzae Type B
Conjugate Vaccine (adsorbed)
|
| Brand Name |
Infanrix Hexa
|
| Dosage Strength |
|
| Dosage Form |
Suspension for Injection (IM) (Preservative-free)
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
-
|
| Packaging |
1 ml Type I glass pre-filled syringe (DTPa-HBV-IPV
component) + 3 mL type I glass vial (Hib component) + 2 sterile needles (256 x 1") (Box of 1's)
|
| Manufacturer |
GlaxoSmithKline Biologicals SA
|
| Country of Origin |
Belgium
|
| Trader |
|
| Importer |
GlaxoSmithKline Philippines Inc.
|
| Distributor |
|
| Application Type |
-
|
| Issuance Date |
27 November 2020
|
| Expiry Date |
11 February 2025
|